Sign in to fuzzto save your conversations, follow your research and come back anytime.
Sotac Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.75 | 19.65 | 18.08 | 24.97 | 26.67 | 25.74 | 26.45 | 25.25 | 27.35 |
| Expenses | 36.35 | 17.88 | 15.67 | 22.63 | 24.59 | 22.83 | 25.27 | 23.03 | 25.24 |
| EBITDA | 3.4 | 1.77 | 2.41 | 2.34 | 2.08 | 2.91 | 1.18 | 2.22 | 2.11 |
| Depreciation | 1.11 | 0.56 | 0.61 | 0.6 | 0.78 | 0.83 | 0.88 | 0.75 | 0.74 |
| EBIT | 2.29 | 1.21 | 1.8 | 1.74 | 1.3 | 2.08 | 0.3 | 1.47 | 1.37 |
| Interest | 1.06 | 0.27 | 0.64 | 0.46 | 0.67 | 0.99 | 0.35 | 0.42 | 0.6 |
| Profit Before Tax | 1.23 | 0.94 | 1.16 | 1.28 | 0.63 | 1.09 | -0.05 | 1.05 | 0.77 |
| Net Profit | 1.02 | 0.58 | 1.04 | 1.08 | 0.65 | 0.91 | 1.65 | 1.46 | 0.46 |
| EPS | 4.41 | 0.29 | 1.58 | 1.01 | 0.58 | 0.82 | 1.49 | 1.32 | 0.42 |
| Metric (₹ crore) | FY20 | FY21 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 0.06 | -0.31 | 8.14 | -16.08 | -4.35 | 16.85 |
| Investing Cash Flow | -11.75 | -3.23 | -11.67 | -19.68 | -13.62 | -6.9 |
| Financing Cash Flow | 11.4 | 3.38 | 13.14 | 29.49 | 16.11 | -10.34 |
| Net Cash Flow | -0.29 | -0.16 | 9.61 | -6.27 | -1.86 | -0.39 |
| Metric (₹ crore) | FY20 | FY21 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 4.72 | 2.56 | 19.69 | 49.33 | 58.42 | 64.57 |
| Total Liabilities | 25.67 | 32.13 | 53.95 | 56 | 65.91 | 68.9 |
| Total Assets | 30.38 | 34.7 | 73.64 | 105.33 | 124.33 | 133.47 |